Program design
- Vironix
- Leads the operating assessment and configures devices, staffing, documentation, reporting, and implementation workflows.
- Your organization
- Provides organizational context and approves the clinical and operational model.
Vironix Health helps providers transform RPM into measurable clinical and financial success — eliminating friction with end-to-end Virtual Care Management solutions and services.

Support patient identification, consent, education, activation, and ongoing engagement instead of stopping at device delivery.
Coordinate cellular connected devices, fulfillment, training, replacements, and support around the approved monitoring plan.
Trained monitoring staff review routine program activity, conduct outreach, and route qualifying concerns under practice-approved protocols.
Organize time, care activity, and device data into reports for the practice's billing team or billing partner.
Establish a workable launch process first, then evaluate available EHR and workflow integration pathways with the practice.
Use operational, engagement, and clinical reporting to evaluate participation, workflow performance, and program trends.
One connected workflow
The operating model is configured with each organization before patients begin monitoring.
The practice confirms clinical appropriateness while Vironix supports population review, outreach, consent, and enrollment workflows.
Patients receive an approved device, education, and support for transmitting physiologic measurements securely.
Monitoring staff review routine activity, follow up within the agreed scope, and help patients remain engaged with the program.
Vironix follows the practice-approved escalation protocol and routes information that requires clinical review to the designated contact.
Organized activity and performance reporting supports the practice's billing workflow and ongoing program improvement.
Clear program ownership
Exact responsibilities, contacts, protocols, and response expectations are agreed with each organization before launch.
Published Vironix program results
These observational results describe the populations and periods reported in the linked Vironix analyses. They do not guarantee the same result for every patient or program.
60 days
In one Vironix RPM analysis, 25–30% of systolic readings initially exceeded 150 mmHg. The reported range declined to 0–15% over 60 days.
Review the 60-day analysis150 days
In a program serving patients with CKD, COPD, and diabetes, the share of systolic readings above 150 mmHg reportedly declined from almost 30% to about 5% over 150 days.
Review the 150-day analysisA defined path to launch
Implementation aligns the technology, people, protocols, and documentation needed to run the program consistently.
Review the patient population, current staffing, device needs, workflows, billing process, and program goals.
Establish enrollment, monitoring, escalation, documentation, reporting, and communication workflows with named owners.
Train the participating teams, activate approved patients, distribute devices, and monitor early operational performance.
Review participation, workflow, clinical, and financial trends and adjust the program with the organization over time.
| CPT Code | Description |
|---|---|
| 99453 | Initial setup and patient education on device use |
| 99445 | Device supply with transmission for 2–15 days in a 30-day period (new for 2026) |
| 99454 | Device supply with transmission, 16–30 days in 30-day period |
| CPT Code | Description |
|---|---|
| 99470 | First 10 minutes of treatment management with required interactive communication (new for 2026) |
| 99457 | First 20 minutes treatment management with interactive communication |
| 99458 | Each additional 20 minutes |
Tell us about your patient population, current workflow, and program goals. We can help you evaluate the technology, devices, staffing, implementation approach, and responsibilities required.